Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women

ClinicalTrials.gov ID: NCT00110487

Public ClinicalTrials.gov record NCT00110487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 10:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study of the Effect of ERB-041 in the Reduction of Symptoms Associated With Endometriosis in Reproductive-Age Women

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this investigational study is to determine if a study medication is safe and effective in reducing the symptoms associated with endometriosis; if the study medication reduces the need for pain medication for endometriosis symptoms; and if the study medication improves a participant's ability to carry out daily activities. Qualified participants will receive no cost treatment, which may include study-related examinations, diagnostic procedures including a Pap smear, laboratory testing, and a mammogram (aged 40-45). Qualified participants will also receive study medication at no cost. As a participant, the study volunteer may also experience the satisfaction of knowing she is helping the advancement of women's health care.

Study identification

NCT ID
NCT00110487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
200 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2005 (Type not available)
Primary completion
Not listed
Completion
Dec 2006 (Actual)
Last update posted
May 1, 2015

2005 – 2006

United States locations

U.S. sites
46
U.S. states
23
U.S. cities
44
Facility City State ZIP Site status
Not listed Phoenix Arizona 85015 —
Not listed Tucson Arizona 85710 —
Not listed Carmichael California 95608 —
Not listed La Jolla California 92093 —
Not listed Redding California 96001 —
Not listed San Diego California 92123 —
Not listed Lakewood Colorado 80228 —
Not listed Aventura Florida 33180 —
Not listed Boynton Beach Florida 33437 —
Not listed Celebration Florida 34747 —
Not listed Clearwater Florida 33758 —
Not listed Miami Florida 33136 —
Not listed Miami Florida 33143 —
Not listed New Port Richey Florida 34652 —
Not listed Ocala Florida 34471 —
Not listed Palm Harbor Florida 34684 —
Not listed Alpharetta Georgia 30005 —
Not listed Atlanta Georgia 30342 —
Not listed Arlington Heights Illinois 60005 —
Not listed Champaign Illinois 61820 —
Not listed Chicago Illinois 60611 —
Not listed Chicago Illinois 60637 —
Not listed Oak Brook Illinois 60523 —
Not listed South Bend Indiana 46601 —
Not listed Shreveport Louisiana 71103 —
Not listed Lanham Maryland 20706 —
Not listed Laurel Maryland 20707 —
Not listed Detroit Michigan 48201 —
Not listed Chaska Minnesota 55318 —
Not listed Chesterfield Missouri 63017 —
Not listed Las Vegas Nevada 89104 —
Not listed Berlin New Jersey 08009 —
Not listed Charlotte North Carolina 28209 —
Not listed Fargo North Dakota 58104 —
Not listed Cincinnati Ohio 45267 —
Not listed Cleveland Ohio 44195 —
Not listed Eugene Oregon 97401 —
Not listed Greenville South Carolina 29605 —
Not listed Greer South Carolina 29651 —
Not listed Dallas Texas 75390-9032 —
Not listed Fort Worth Texas 76104 —
Not listed Webster Texas 77598 —
Not listed Sandy City Utah 84070 —
Not listed Norfolk Virginia 23507-1627 —
Not listed Richmond Virginia 23298 —
Not listed Madison Wisconsin 53792-6188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00110487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2015 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00110487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →